Robert W. Baird Cuts Healthpeak Properties Price Target

Analysts lower price target on REIT stock to $19 from $20

Apr. 6, 2026 at 2:05pm

Got story updates? Submit your updates here. ›

Investment firm Robert W. Baird has lowered its price target on Healthpeak Properties (NYSE: DOC) from $20 to $19 per share, while maintaining an 'outperform' rating on the real estate investment trust's stock. The revised target suggests a potential upside of 14% from the stock's previous closing price.

Why it matters

Healthpeak Properties is a major REIT focused on healthcare-related real estate, including life science research facilities, medical offices, and senior housing. Analyst price target adjustments can influence investor sentiment and trading activity around the stock.

The details

In a research note, Robert W. Baird analysts cited the revised price target, which they say points to a potential upside of 14% from Healthpeak's previous closing price. The firm maintained its 'outperform' rating on the REIT's stock. Healthpeak Properties has received a mix of 'buy' and 'hold' ratings from various equity research analysts in recent months.

  • The new price target was issued on April 6, 2026.

The players

Robert W. Baird

An investment firm that provides research coverage and analysis on Healthpeak Properties.

Healthpeak Properties

A real estate investment trust (REIT) that specializes in healthcare-related properties, including life science research facilities, medical offices, and senior housing.

Got photos? Submit your photos here. ›

The takeaway

The revised price target from Robert W. Baird suggests analysts see potential upside in Healthpeak Properties' stock, though the lowered target also indicates some near-term uncertainty around the REIT's performance. Investors will likely be watching for any further updates or commentary from the company and other analysts covering the stock.